Caprelsa
Drug timelines are a Plus or Pro feature.
29 regulatory and trial events tracked for Caprelsa, covering 2011-04-06 to 2026-08-05. Get the full timeline:
Most recent: EMA Authorised: Caprelsa (vandetanib) — Esteve Pharmaceuticals, S.A.